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Abstract. Cardiopulmonary bypass (CPB) is associ-
ated with a systemic inﬂammatory response. Pre-by-
pass steroid administration may modulate the
inﬂammatory response, resulting in improved post-
operative recovery. We performed a prospective study
in the departments of cardiovascular surgery and
pediatric intensive care medicine of two university
hospitals that included 50 infantswho underwent heart
surgery. Patients received either prednisolone (30 mg/
kg) added to the priming solution of the cardiopul-
monary bypass circuit (steroid group) or no steroids
(nonsteroid group). Clinical outcome parameters in-
clude therapy with inotropic drugs, oxygenation,
blood lactate, glucose, and creatinine, and laboratory
parameters of inﬂammation include leukocytes,
C-reactive protein, and interleukin-8. Postoperative
recovery (e.g., the number, dosage, and duration of
inotropic drugs as well as oxygenation) was similar in
patients treated with or without steroids when cor-
rected for the type of cardiac surgery performed. After
CPB, there was an inﬂammatory reaction, especially in
patients with a long CPB time. Postoperative plasma
levels of interleukin-8 were correlated with the dura-
tion of CPB time (r = 0.62, p < 0.001). Administra-
tion of steroids had no signiﬁcant impact on the
laboratory parameters of inﬂammation. Administra-
tion of prednisolone into the priming solution of the
CPB circuit had no measurable inﬂuence on post-
operative recovery and did not suppress the in-
ﬂammatory response.
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Cardiac surgery with the aid of cardiopulmonary
bypass (CPB) leads to an acute inﬂammatory re-
sponse associated with activation of complement,
release of cytokines and chemokines into the circu-
lation, as well as activation of inﬂammatory cells
[14, 21]. Elevated levels of proinﬂammatory cyto-
kines, such as tumor necrosis factor-a, interleukin
(IL)-6, and IL-8, have been reported [6, 11]. This
inﬂammatory response is counterbalanced by a
complex system of inhibitors, such as IL-10 and sol-
uble cytokine receptors [7, 10, 25].
Several therapeutic aspects have been proposed
to modulate the inﬂammatory response, such as
hemoﬁltration [12] or the use of various pharmaco-
logical agents, including steroids [17], nonsteroidal
anti-inﬂammatory drugs [28], pentoxyphylline [5],
aprotinin [22], or complement receptor blocking
agents [2]. Although steroids have been used for years
to attenuate post-bypass inﬂammation, data to sup-
port this derive almost entirely from trials in adults
with coronary artery disease. Even in adults, steroid
use for cardiac surgery is controversial and data in
children are rare.
The aim of this prospective study was to analyze
clinical parameters of outcome as well as markers of
inﬂammation with and without pre-bypass adminis-
tration of steroids in infants undergoing heart surgery
with CPB.
Patients and Methods
Patients and Blood Sampling Protocol
The study was carried out at two cardiovascular surgery units and
pediatric intensive care units. The study was approved by the localCorrespondence to: P. Gessler, email: peter.gessler@kispi.unizh.ch
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ethics committee of both hospitals. Informed written consent was
obtained from the parents of each child.
The study included 50 consecutive patients in both centers
(the parents of 2 children refused to participate in the study). As
part of routine clinical care, all children weighing more than 7 kg
received no steroids. Children weighing £ 7 kg received steroids
into the priming solution of the CPB circuit at one center but not at
the other. Accordingly, patients were grouped in a nonsteroid
group and a steroid group (Table 1). During the study, only infants
older than 3 months of age were included because of the known
immaturity of the immune system in younger infants. All patients
were operated on by the same two surgeons.
Cardiovascular function was assessed by the number and dos-
age of inotropic drugs used during the ﬁrst 24 hours after CPBaswell
as the total duration of inotropic therapy. Postoperative inotropic
support was done according to age-adapted reference values for
blood pressure and clinical variables (i.e., skin perfusion and urine
output) using dopamine, dobutamine, milrinone, adrenaline, or
(rarely) noradrenaline, either as a single drug or in combination. In
order to quantify the inotropic drugs used during the ﬁrst 24 hours
after CPB, a score was created with the following items: dopamine
(dobutamine) £ 5 lg/kg/min = 1, dopamine (dobutamine) >5 lg/
kg/min = 2, milrinone £ 0.4 lg/kg/min = 1, milrinone >0.4 lg/
kg/min = 2, (nor-)epinephrine £ 0.1 lg/kg/min = 1, and (nor-
)epinephrine >0.1 lg/kg/min = 2. Prescription of the drugs was
done by a team of intensive care physicians who were unaware of the
laboratory results obtained for research purpose.
Postoperatively, patients were ventilated (Draeger Evita IV,
Luebeck, Germany) using biphasic positive airway pressure mode.
The fraction of inspired oxygen was adjusted to maintain an
arterial oxygen tension of 10 kPa or greater. Respiratory function
was determined as the ratio of arterial oxygen tension to fraction of
inspired oxygen (PaO2/FiO2) calculated 24 hours after the end of
CPB and the total duration of mechanical ventilation. The ratio
PaO2/FiO2 was only used in patients during the second part of the
study, when repair of cardiac lesion resulted in complete separation
of pulmonary and systemic circulation in all cases. Mechanical
ventilation was discontinued according to a standard weaning
protocol, which is followed for all patients before extubation.
Arterial blood samples for cytokine assays were collected from
each patient before and 2 hours after CPB. Blood samples were
immediately centrifuged and the plasma stored at )70C until
analysis.
CPB Management
The extracorporeal circuit (ECC) consisted of a roller pump, car-
diotomy reservoir, tubing set, and oxygenator (Dideco, Mirandola,
Italy). In both hospitals, the circuit was primed with a mixture of
red blood cell concentrate, human albumine, sodium bicarbonate
(8.4%), mannitol (20%), magnesium chloride, aprotinin (Bayer,
Leverkusen, Germany), and heparin (Roche Pharma, Grenzach,
Switzerland). Aprotinin was used in all patients in the same dosage
of 50,000 U/kg. However, in Zurich, patients weighing less than
7 kg received 30 mg/kg prednisolone (Ultracorten H, Novartis
Pharma, Basel, Switzerland) into the priming solution of CPB
immediately before the start of CPB, whereas in children weighing
more than 7 kg no steroids were added. In Berne, none of the
patients received steroids. Cardioplegia solutions were the standard
Buckberg potassium-based solutions mixed with blood in a ratio of
4:1 (blood:cardioplegia). CPB was conducted in mild hypothermia
(32C) with ﬂow rates between 2.4 and 2.8 L/min/m2. Ultraﬁltra-
tion was performed in all patients in a standardized manner during
the rewarming period using a blood concentrator (20 ml per minute
resulting in a volume of 600 ± 200 ml). Heparin was neutralized
with protaminhydrochloride (ICN Pharmaceuticals, Frankfurt,
Germany) after the end of CPB.
Plasma Levels of IL-8
Concentrations of IL-8 were measured with a commercial enzyme-
linked immunosorbent assay kit (Quantikine, R&D Systems)
according to the manufacturers recommendations.
Statistical Analysis
Data are expressed as the median value and interquartile range.
Two-tailed tests were used for all statistical comparisons. Statistical
signiﬁcance was declared when p < 0.05. Comparisons between
Table 1. Patient characteristics
Steroid group (n = 24) Nonsteroid group (n = 26) p value
Age (months) 5.0 (4.0–7.3) 21.5 (8.3–48.8) 0.0015
Body weight (kg) 5.8 (4.6–6.4) 11.4 (7.5–15.5) 0.0004
Body length (cm) 61.5 (56–65) 90.5 (69.6–105.0) 0.0004
Atrial septal defect 2 5
Ventricular septal defect 4 4
Complete atrioventricular canal 3 5
Aortic stenosis 2 5
Pulmonary stenosis 1 1
Single ventricle 2 1
Hypoplastic left heart syndrome 3 0
Tetralogy of Fallot 2 4
Double-outlet right ventricle 2 0
Transposition of the great arteries 1 0
Tricuspid atresia 1 0
Total anomalous pulmonary venous return 1 1
CPB time (min) 134 (103–182) 110 (85–136) 0.0637
Cross-clamp time (min) 44 (0–61) 42 (18–53) 0.8688
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patients with and without steroid therapy with respect to clinical
variables were done using the Mann–Whitney U-test. Analysis of
the data at the diﬀerent time points was performed using an
analysis of variance for repeated measurements. Correlations be-
tween continuous variables were assessed using Spearmans rho
correlation coeﬃcient.
Results
Inﬂammatory Reaction after CPB
Plasma concentrations of IL-8 before CPB were less
than 10 pg/ml in all patients and elevated during as
well as 1 and 3 hours after CPB (p < 0.001) (Fig. 1).
There was a correlation between levels of IL-8 1 hour
after CPB and the CPB time (r = 0.62, p < 0.001).
The median duration of CPB in patients treated with
steroids was 134 minutes compared with 110 minutes
in the nonsteroid group (Table 1). Furthermore, CPB
time and aortic cross-clamp time in patients treated in
both centers were comparable, demonstrating no
statistically signiﬁcant diﬀerences (data not shown).
In patients treated with or without steroids, no sig-
niﬁcant diﬀerences in plasma IL-8 levels were
detectable 1 and 3 hours after CPB (Fig. 1). Again,
no center eﬀect could be detected and postoperative
plasma levels of IL-8 at both centers were equal.
Twenty-four hours after CPB, total neutrophil
cell (TNC) counts of infants were signiﬁcantly in-
creased compared to preoperative values interquar-
tile. Postoperatively, median TNC counts in the
steroid group were 8.4 g/L (range, 6.7–10.3) vs pre-
operative 2.7 g/L (1.8–5.4) (p = 0.002); TNC counts
in the nonsteroid group were 8.5 g/L (5.2–9.5) post-
operatively vs 4.2 g/L (2.5–6.4) preoperatively
(p = 0.004), respectively. No statistically signiﬁcant
diﬀerence could be detected between the postopera-
tive leukocyte counts of the steroid group and the
nonsteroid group (Table 2) as well as between the
leukocyte counts of both centers (data not shown).
Median concentrations of CRP were lower in infants
after administration of steroids; however, the diﬀer-
ence was not statistically signiﬁcant.
Clinical Outcome
Cardiac diagnosis in the steroid and nonsteroid
groups was diﬀerent due to the limitation of steroid
treatment to infants weighing less than 7 kg. In order
to compare patients with respect to the clinical out-
come after steroid treatment, patients of both centers
were matched regarding to age, weight, and cardiac
diagnosis. In patients treated with or without steroids,
CPB and aortic cross-clamp times were statistically
not diﬀerent: median CPB time in the steroid group
was 124 minutes (range, 108–133) and in the nonste-
roid group 99 minutes (range, 82–105) (p = 0.0892);
median aortic cross-clamp time in the steroid group
was 50 minutes (range, 22–60) and in the nonsteroid
group 46 minutes (range, 32–51) (p = 0.7338).
Cardiovascular function 24 hours after CPB was
similar in both groups. Median inotropic score
reﬂecting the kind and dose of inotropic drugs used
during the ﬁrst 24 hours after CPB was 2.1 (range,
1.0–3.0) in the steroid group compared to 2.6 (range,
2.0–3.8) in the nonsteroid group (p = 0.3826)
(Table 3). Moreover, the total duration of inotropic
therapy was statistically not diﬀerent in both groups:
median duration in the steroid group was 79.9 hours
(range, 57.5–99.3) and in the nonsteroid group 62.5
hours (range, 34.0–72.3) (p = 0.1856).
With respect to the respiratory function, the ratio
of PaO2/FiO2 assessed at 24 hours after CPB was
equal in both groups. The median duration of
mechanical ventilation was 75.0 hours in the steroid
group (range, 40.8–95.8) and in the nonsteroid group
58.0 hours (range, 29.3–93.8) (p = 0.3443).
Blood concentrations of lactate, glucose, and
hematocrit levels were similar in both groups. Blood
creatinine levels were signiﬁcantly increased after
CPB compared with values before CPB in both
groups. In the steroid group, creatinine before CPB
was 43.5 lmol/L (range, 40.5–49.3) compared to 50.5
lmol/L (range, 48.3–55.3) after CPB (p = 0.0322). In
the nonsteroid group, creatinine increased from 45.0
lmol/L (range, 42.0–48.8) to 52.5 lmol/L (range,
44.8–59.8) (p = 0.0039). The postoperative increase
in creatinine was similar in both groups (p = 0.9719).
In each group, one patient died postoperatively due
to severe cardiac failure.
Fig. 1. Plasma levels of interleukin-8 during cardiopulmonary by-
pass (CPB), 1 hour after CPB, and 3 hours after CPB in patients
treated in Zurich with or without steroids. The box and whisker
plots show the median (horizontal lines), interquartile ranges (bars),
and the extremes.
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Discussion
After CPB in infants, there was an impairment of
cardiovascular and respiratory function as well as
laboratory signs of inﬂammation. Administration of
steroids before CPB had no inﬂuence on clinical
postoperative recovery and did not suppress the
inﬂammatory response.
Preoperative administration of steroids has been
suggested to suppress the inﬂammatory reaction in-
duced by CPB. Administration of glucocorticoids
prior to CPB may attenuate endotoxin release and
complement activation [8, 27]. Prednisolone lowers
post-CPB concentrations of the proinﬂammatory
cytokines tumor necrosis factor-a, IL-6, and IL-8 and
increases concentrations of the anti-inﬂammatory
cytokines IL-10 and IL-1RA [15, 19]. Corticosteroids
also attenuate post-CPB leukocyte activation, neu-
trophil adhesion molecule upregulation, and pulmo-
nary neutrophil sequestration [8, 15, 18]. In the
current study, laboratory indices of inﬂammation
were similar in patients with and without steroid
pretreatment. Increased inﬂammatory response with
elevated levels of IL-8 was reported and conﬁrmed in
this study after increased duration of CPB time [13,
16]. Median CPB time in patients treated with or
without steroids was approximately the same and the
laboratory indices of inﬂammation were similar for
both groups. Moreover, when patients were matched
for age and cardiac diagnosis, the inﬂammatory
reaction was the same irrespective of steroid therapy,
as shown by the comparison of treatment at the two
diﬀerent cardiosurgery centers. The lack of a
demonstrable immunosuppressive eﬀect may be due
to the dose and timing of steroids [20, 26]. Indeed, a
recent study showed lower inﬂammatory mediator
expression when combined pre- and intraoperative
steroid administration was given compared to intra-
operative treatment with methylprednisolone (30 mg/
kg per dose) alone [23].
The clinical implications of corticosteroid use are
not fully elucidated, and clear beneﬁt is not yet
demonstrated [3]. Moreover, two recent clinical
investigations of steroid administration in adults
demonstrated no beneﬁt or even an adverse outcome
after steroid administration [4, 9, 24]. However, in
children, Schroeder et al. [23] demonstrated improved
oxygen delivery in the ﬁrst 24 hours after congenital
heart surgery with combined pre- and intraoperative
steroid administration, but no signiﬁcant diﬀerence
was shown between the length of mechanical venti-
lation and the inotropic support. In order to compare
the clinical outcome of children after cardiac surgery,
patients of two centers were matched with respect to
cardiac diagnosis, weight, and age. Neither inotropic
support nor respiratory function after CPB were
improved in patients treated with steroids. Again, the
lack of beneﬁt of steroid therapy in our study may be
due to the dosage and timing of steroid administra-
tion. Moreover, infants in the study by Schroeder
et al. were younger than those in our study and the
CPB time was much longer, inducing an increased
inﬂammatory reaction compared with the current
study. Bronicki et al. [1] used dexamethasone (1 mg/
kg intravenously) in children prior to CPB and re-
ported improved postoperative respiratory function
and less inﬂammatory response (e.g., decreased levels
of IL-6 and tumor necrosis factor-a) without aﬀect-
ing neutrophil cell counts. Noteworthy in this study,
CPB time and aortic cross-clamp time were
Table 2. Indices of inﬂammation after CPB
Steroid group (n = 24) Nonsteroid group (n = 26) p value
TNC (g/L) (24 hr) 8.4 (6.7–10.3) 8.5 (5.2–9.5) 0.6165
Monocytes (g/L) (24 hr) 0.9 (0.5–1.2) 0.8 (0.5–1.2) 0.9835
Lymphocytes (g/L) (24 hr) 1.7 (1.4–2.3) 1.8 (1.3–2.6) 0.7726
CRP (mg/L) (24 hr) 51.0 (33.0–105.5) 73.0 (55.0–117.5) 0.2211
CRP, C-reactive protein; TNC, total neutrophil cell count.
Table 3. Clinical outcome parameters 24 hours after CPB
Steroid group (n = 10) Nonsteroid group (n = 10) p value
Inotropic score 2.1 (1.0–3.0) 2.6 (2.0–3.8) 0.3826
PaO2/FiO2 (mmHg) 266.5 (227–318) 267.5 (183–363) 0.8880
Lactate (mmol/L) 1.0 (0.8–1.6) 1.3 (1.1–1.9) 0.1039
Glucose (mmol/L) 7.0 (6.7–8.5) 5.6 (4.7–5.9) 0.6953
Creatinine (lmol/L) 50.5 (48.3–55.3) 52.5 (44.8–59.8) 0.9719
Hematocrit (%) 34.5 (33.3–36.0) 36.0 (30.5–39.0) 0.5566
PaO2/FiO2, ratio of arterial oxygen tension to fraction of inspired oxygen.
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comparable to those of the current study, suggesting
that dexamethasone at 1 mg/kg intravenously may be
superior to 30 mg/kg prednisolone given into the
priming solution before CPB.
Glucocorticoids are antianabolic agents that re-
sult in decreased synthesis of new protein, attenua-
tion of immunity, and impairment of insulin action.
In our study, blood glucose concentrations 24 hours
after CPB were not diﬀerent in patients treated with
or without steroids. Moreover, none of our patients
experienced septic complications.
The lack of beneﬁt of steroid treatment in our
study may be due to the less damaging eﬀect of CPB
components (e.g., the oxygenator causing less
inﬂammation). Equipment and conduction of CPB
were comparable in both centers and the main
operative data, CPB time and aortic cross-clamp
time, were similar. The majority of the infants had a
favorable course after heart surgery. Perhaps another
spectrum of operations or a diﬀerent management of
CPB would have caused more inﬂammatory reaction
and thereby steroid administration would have
demonstrated a more powerful immunosuppressive
eﬀect. An important shortcoming of our study is the
fact that it is not a randomized, double-blind study.
Indeed, steroids were given in one unit but not in the
other. However, the clinicians responsible for the
treatment of the children in both units were not in-
formed about the results of the laboratory parameters
of inﬂammation, and therapy with inotropic drugs, as
well as mechanical ventilation, was done according to
the same guidelines. Moreover, this is a noncom-
mercial study and there is no conﬂict of interest.
In conclusion, in this group of infants older than
3 months of age, administration of steroids did not
show a signiﬁcant impact on the clinical outcome and
the degree of the inﬂammatory response following
cardiac surgery. The lack of suppression of the
inﬂammatory reaction may be due to the dose and
timing of steroid administration, the lower inﬂam-
matory reaction in patients with shorter time on CPB
and less severe operative trauma, or an age older than
3 months at the time of surgery.
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